Indo-Bangla Pharmaceuticals Limited (DSE:IBP)
Bangladesh
· Delayed Price · Currency is BDT 12.50
-0.30 (-2.34%)
At close: Apr 28, 2026
DSE:IBP Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jul '22 Jul 1, 2022 | Jul '21 Jul 1, 2021 | 2020 - 2016 |
| Market Capitalization | 1,453 | 1,522 | 1,546 | 1,975 | 2,036 | 2,186 | Upgrade
|
| Market Cap Growth | -1.57% | -1.50% | -21.77% | -2.97% | -6.88% | -1.96% | Upgrade
|
| Enterprise Value | 1,470 | 1,544 | 1,570 | 2,047 | 2,079 | 2,262 | Upgrade
|
| Last Close Price | 12.50 | 13.08 | 13.27 | 16.96 | 17.75 | 18.68 | Upgrade
|
| PE Ratio | - | - | - | 234.98 | 80.87 | 16.23 | Upgrade
|
| PS Ratio | 6.57 | 8.27 | 8.75 | 5.28 | 4.20 | 2.80 | Upgrade
|
| PB Ratio | 1.00 | 1.05 | 0.98 | 1.22 | 1.25 | 1.35 | Upgrade
|
| P/TBV Ratio | 1.00 | 1.05 | 0.98 | 1.22 | 1.25 | 1.35 | Upgrade
|
| P/FCF Ratio | 26.00 | 26.30 | 65.38 | 46.03 | 42.77 | - | Upgrade
|
| P/OCF Ratio | 25.74 | 26.05 | 45.77 | 27.08 | 23.33 | 14.48 | Upgrade
|
| EV/Sales Ratio | 6.65 | 8.38 | 8.89 | 5.47 | 4.29 | 2.89 | Upgrade
|
| EV/EBITDA Ratio | 102.76 | 350.91 | 328.22 | 30.53 | 27.74 | 10.81 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 71.35 | 58.07 | 13.05 | Upgrade
|
| EV/FCF Ratio | 26.32 | 26.67 | 66.42 | 47.69 | 43.67 | - | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | 0.03 | 0.05 | 0.05 | Upgrade
|
| Debt / EBITDA Ratio | 1.36 | 4.55 | 5.06 | 0.65 | 1.01 | 0.41 | Upgrade
|
| Debt / FCF Ratio | 0.35 | 0.35 | 1.02 | 1.02 | 1.58 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.24 | 3.56 | 2.89 | 0.48 | 0.62 | 0.24 | Upgrade
|
| Net Debt / FCF Ratio | 0.32 | 0.27 | 0.58 | 0.75 | 0.98 | -1.00 | Upgrade
|
| Asset Turnover | 0.12 | 0.10 | 0.10 | 0.20 | 0.26 | 0.43 | Upgrade
|
| Inventory Turnover | 1.38 | 1.23 | 0.92 | 1.55 | 1.76 | 2.39 | Upgrade
|
| Quick Ratio | 2.03 | 1.71 | 2.12 | 1.88 | 1.61 | 1.65 | Upgrade
|
| Current Ratio | 3.84 | 3.62 | 4.95 | 4.26 | 3.50 | 3.57 | Upgrade
|
| Return on Equity (ROE) | -1.69% | -2.43% | -2.56% | 0.52% | 1.55% | 8.57% | Upgrade
|
| Return on Assets (ROA) | -0.49% | -0.85% | -0.80% | 0.95% | 1.18% | 5.95% | Upgrade
|
| Return on Invested Capital (ROIC) | -0.94% | -1.57% | -1.46% | 0.59% | 1.70% | 8.45% | Upgrade
|
| Return on Capital Employed (ROCE) | -0.90% | -1.50% | -1.40% | 1.60% | 2.10% | 10.00% | Upgrade
|
| Earnings Yield | -1.76% | -2.42% | -2.65% | 0.43% | 1.24% | 6.16% | Upgrade
|
| FCF Yield | 3.85% | 3.80% | 1.53% | 2.17% | 2.34% | -2.26% | Upgrade
|
| Dividend Yield | 0.12% | 0.11% | 0.07% | - | 0.56% | 2.14% | Upgrade
|
| Payout Ratio | - | - | - | 123.72% | 98.46% | 19.97% | Upgrade
|
| Buyback Yield / Dilution | 2.03% | - | - | - | -2.17% | - | Upgrade
|
| Total Shareholder Return | 2.15% | 0.11% | 0.07% | - | -1.61% | 2.14% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.